---
figid: PMC7967218__ijms-22-02778-g002
figtitle: Histone acetylation regulates genes involved in cancer progression
organisms:
- Homo sapiens
- Mus musculus
pmcid: PMC7967218
filename: ijms-22-02778-g002.jpg
figlink: pmc/articles/PMC7967218/figure/ijms-22-02778-f002/
number: F2
caption: Histone acetylation regulates genes involved in cancer progression. Histone
  acetylation is an activating histone modification that favors gene transcription.
  H3K4Ac marks are present on the promoters of several genes, GLI1, SMO, FOXF1, Bmi1,
  and SIRT2, which are upregulated in cancer, favoring tumor progression. Upon SNAI1/2
  activation, increased H3K9 acetylation has been observed on the promoter of TGFBR2,
  causing its upregulation. Critical acetyltransferases TIP60, GCN5, PCAF, and p300
  catalyze histone acetylation of metastasis-promoting genes. hMOF, a H4K16 histone
  acetyltransferase normally maintains the expression of EMT-related tumor suppressor
  genes, such as TMS1, CDH1, and ESR1, but is often downregulated in cancer. TIP60
  is also commonly downregulated in various tumors, where it prevents the activity
  of anti-tumor DDR and p53 pathways, indicating how reduction in histone acetylation
  promotes cancer progression. HDAC3 can also be detected on the promoters of activated
  mesenchymal genes, even though most HDACs are associated with gene repression. Upon
  Notch signaling activation, H3K4Ac is removed by HDAC3, allowing for Notch-mediated
  expression of EMT-related genes. Profilin-2 interacts with HDAC1 and inhibits its
  binding to the promoters of Smad2 and Smad3, causing Smad protein activation and
  subsequently enhancing TGF-β-induced EMT and angiogenesis. HDACs also catalyze H3K4/56
  deacetylation at the CDH1 promoter, thus repressing E-cadherin. Similarly, HDAC1
  and 2 are recruited by ZEB1 to CDH1 promoter, inducing its repression. In the same
  context, ZEB1 recruits SIRT1, a nicotinamide adenine dinucleotide (NAD)-dependent
  deacetylase, associated with a global H3K27 deacetylation and reduced H3K9Ac and
  H3K27Ac levels on the promoters of CDH1 and other epithelial genes, such as EPCAM,
  ST14, ESRP1, and RAB25, promoting EMT and metastasis. Finally, overexpression of
  FLIP leads to the upregulation of the anti-apoptotic Bcl-XL, inhibiting the anoikis
  apoptotic pathway. HDAC inhibition prevents this outcome by reducing FLIP levels
  and inducing apoptosis of cancer cells, suggesting that HDACs participate in anoikis
  resistance of cancer cells through yet unknown mechanisms.
papertitle: Prominent Role of Histone Modifications in the Regulation of Tumor Metastasis.
reftext: Mariam Markouli, et al. Int J Mol Sci. 2021 Mar;22(5):2778.
year: '2021'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9194982
figid_alias: PMC7967218__F2
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC7967218__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7967218__ijms-22-02778-g002.html
  '@type': Dataset
  description: Histone acetylation regulates genes involved in cancer progression.
    Histone acetylation is an activating histone modification that favors gene transcription.
    H3K4Ac marks are present on the promoters of several genes, GLI1, SMO, FOXF1,
    Bmi1, and SIRT2, which are upregulated in cancer, favoring tumor progression.
    Upon SNAI1/2 activation, increased H3K9 acetylation has been observed on the promoter
    of TGFBR2, causing its upregulation. Critical acetyltransferases TIP60, GCN5,
    PCAF, and p300 catalyze histone acetylation of metastasis-promoting genes. hMOF,
    a H4K16 histone acetyltransferase normally maintains the expression of EMT-related
    tumor suppressor genes, such as TMS1, CDH1, and ESR1, but is often downregulated
    in cancer. TIP60 is also commonly downregulated in various tumors, where it prevents
    the activity of anti-tumor DDR and p53 pathways, indicating how reduction in histone
    acetylation promotes cancer progression. HDAC3 can also be detected on the promoters
    of activated mesenchymal genes, even though most HDACs are associated with gene
    repression. Upon Notch signaling activation, H3K4Ac is removed by HDAC3, allowing
    for Notch-mediated expression of EMT-related genes. Profilin-2 interacts with
    HDAC1 and inhibits its binding to the promoters of Smad2 and Smad3, causing Smad
    protein activation and subsequently enhancing TGF-β-induced EMT and angiogenesis.
    HDACs also catalyze H3K4/56 deacetylation at the CDH1 promoter, thus repressing
    E-cadherin. Similarly, HDAC1 and 2 are recruited by ZEB1 to CDH1 promoter, inducing
    its repression. In the same context, ZEB1 recruits SIRT1, a nicotinamide adenine
    dinucleotide (NAD)-dependent deacetylase, associated with a global H3K27 deacetylation
    and reduced H3K9Ac and H3K27Ac levels on the promoters of CDH1 and other epithelial
    genes, such as EPCAM, ST14, ESRP1, and RAB25, promoting EMT and metastasis. Finally,
    overexpression of FLIP leads to the upregulation of the anti-apoptotic Bcl-XL,
    inhibiting the anoikis apoptotic pathway. HDAC inhibition prevents this outcome
    by reducing FLIP levels and inducing apoptosis of cancer cells, suggesting that
    HDACs participate in anoikis resistance of cancer cells through yet unknown mechanisms.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DDR1
  - DDR2
  - TP53
  - TP63
  - TP73
  - KAT5
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - SNAI1
  - SNAI2
  - SNAI3
  - KAT8
  - HDAC9
  - HDAC1
  - HDAC2
  - HDAC3
  - HDAC8
  - HDAC4
  - HDAC5
  - HDAC7
  - HDAC6
  - HDAC10
  - SIRT1
  - SIRT2
  - SIRT3
  - SIRT4
  - SIRT5
  - SIRT6
  - SIRT7
  - HDAC11
  - KAT2A
  - KAT2B
  - EP300
  - BMI1
  - COMMD3-BMI1
  - TGFBR2
  - SMO
  - SMOX
  - GLI1
  - FOXF1
  - SERINC3
  - PYCARD
  - ESR1
  - CDH1
  - FZR1
  - ST14
  - SMAD3
  - SMAD2
  - CFLAR
  - FIRRM
  - ESRP1
  - EPCAM
  - RAB25
  - ITK
  - SLC22A3
  - H1-0
  - H1-1
  - H1-2
  - H1-3
  - H1-4
  - H1-5
  - H1-6
  - H1-7
  - H1-8
  - H1-10
  - .na.character
  - H2AB1
  - H2AJ
  - H2AZ2
  - H2AX
  - MACROH2A1
  - MACROH2A2
  - H2AZ1
  - H2AC1
  - H2AC6
  - H2AC7
  - H2AC12
  - H2AC14
  - H2AC21
  - H2AC20
  - H2AC25
  - H2BC1
  - H2BC3
  - H2BC5
  - H2BC9
  - H2BC11
  - H2BC12
  - H2BC13
  - H2BC14
  - H2BC15
  - H2BC17
  - H2BC18
  - H2BC19P
  - H2BC20P
  - H2BC21
  - H2BC26
  - H2BC12L
  - H2BW2
  - H2BW1
  - H3-4
  - H3-5
  - H4C7
  - Trp53
  - Kat5
  - Hdac1
  - Hdac1-ps
  - Kat2a
  - Kat2b
  - Hdac3
  - Ep300
  - Sirt1
  - Bmi1
  - Tgfbr2
  - Smo
  - Smox
  - Gli1
  - Foxf1
  - Serinc3
  - Pycard
  - Esr1
  - Cdh1
  - Fzr1
  - St14
  - Smad3
  - Smad2
  - Sirt2
  - Bcl2l1
  - Cflar
  - Firrm
  - Esrp1
  - Epcam
  - Rab25
  - Lamtor2
  - Itk
  - Slc22a3
  - Acetyl
---
